In this episode of Onc Now, medical oncologist Victor Moreno Garcia explores the hurdles of turning early-phase oncology research into real patient benefits. He explains why many therapies fail in Phase I-III trials, the complexity of the tumor microenvironment, and the growing importance of biomarkers and AI. The conversation also covers advances in cell therapy for solid tumors and the future of precision oncology.
Dr. Moreno Garcia, from Complutense University of Madrid and La Paz University Hospital, brings over a decade of experience in early-phase trials and cancer drug development.